Market Size of Osteoarthritis Treatment Industry
![Osteoarthritis Treatment Market Summary](https://s3.mordorintelligence.com/osteoarthritis-treatment-market/1668687696995_osteoarthritis-treatment-market_Market_Summary.webp)
Study Period | 2021 - 2029 |
Market Size (2024) | USD 7.33 Billion |
Market Size (2029) | USD 9.24 Billion |
CAGR (2024 - 2029) | 4.74 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Major Players![]() *Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Osteoarthritis Treatment Market Analysis
The Osteoarthritis Treatment Market size is estimated at USD 7.33 billion in 2024, and is expected to reach USD 9.24 billion by 2029, growing at a CAGR of 4.74% during the forecast period (2024-2029).
The COVID-19 pandemic had a short-term impact on the market growth as it led to the cancelation or postponement of the scheduled treatment procedures and a decrease in the number of new diagnoses of osteoarthritis. According to the article published by PubMed Central in June 2022, there was a significant reduction in the healthcare of orthopedic and trauma patients during the COVID-19 pandemic in the Czech Republic. It also emphasized the healthcare system's shortcomings, including outpatient and inpatient care. Also, COVID-19 impacted pharmaceutical companies' research and development activities along with the delay in clinical trials of several new therapies worldwide, including treatments for osteoarthritis. Hence, the COVID-19 pandemic had a significant impact on the market initially. However, as the number of cases of COVID-19 has declined, the studied market has started to regain traction. It is expected to have healthy growth during the forecast period of the study.
The increasing geriatric population, increasing research & development activities, and funding for osteoarthritis therapeutics are the significant factors driving the growth of the studied market.
As the older population is more susceptible to osteoarthritis, the increase in the global geriatric population is expected to have a significant impact on the studied market. For instance, according to the data published by the UN in 2022, the global population aged 65 years or above is projected to rise from 10% in 2022 to 16% in 2050. The source also claims by 2050, the number of people aged 65 years or over worldwide is projected to be more than twice the number of children under age five and about the same as the children under age 12. Furthermore, according to an article published by PubMed Central in September 2022, osteoarthritis is a significant cause of disability. It is the most common type of arthritis, affecting almost 10% of the global population aged 60 years and above. Hence, the rising geriatric population and the association of old age with osteoarthritis will enhance the market growth during the forecast period.
Also, the increasing awareness among the people, the availability of better treatment options, and the willingness to take up treatment are expected to complement the growth of the osteoarthritis treatment market. For instance, according to the Osteoarthritis (OA) Action Alliance, May is arthritis awareness month. It also stated that osteoarthritis (OA) is the most common form of arthritis.
Additionally, the market players have been adopting various strategies, such as product launches, developments, acquisitions and mergers, and collaborations, and expanding their product portfolio in the studied market and boosting it. For instance, in September 2021, Indian drug manufacturer Lupin Limited launched generic Duexis tablets used to treat the symptoms of rheumatoid arthritis and osteoarthritis in the US.
Therefore, owing to the factors such as the increasing geriatric population, increasing awareness about osteoarthritis, and product launches, the studied market is anticipated to witness growth over the analysis period. However, the high cost associated with hyaluronic acid products and other treatment procedures for osteoarthritis treatment and the side effects related to the available therapies may impede the growth of the osteoarthritis treatment market over the forecast period.
Osteoarthritis Treatment Industry Segmentation
As per the scope of the report, osteoarthritis, also known as degenerative arthritis, is the most commonly occurring chronic condition that affects the joints. It leads to severe joint pain and stiffness of the affected body parts. Several treatments can cure osteoarthritis, including exercise to reduce joint pain and pain medications. The Osteoarthritis Treatment Market is segmented by drugs (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Hyaluronic acid Injection, and other drugs), anatomy (Ankle Osteoarthritis, Hip Osteoarthritis, Knee Osteoarthritis, Shoulder Osteoarthritis, and other anatomies), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value in (USD million) for the above segments.
By Drugs | |
Non-steroidal Anti-inflammatory Drugs (NSAIDs) | |
Corticosteroids | |
Hyaluronic Acid Injection | |
Other Drugs |
By Anatomy | |
Ankle Osteoarthritis | |
Hip Osteoarthritis | |
Knee Osteoarthritis | |
Shoulder Osteoarthritis | |
Other Anatomies |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Osteoarthritis Treatment Market Size Summary
The osteoarthritis treatment market is poised for growth, driven by factors such as the increasing geriatric population and heightened awareness of the condition. The market experienced a temporary setback due to the COVID-19 pandemic, which disrupted treatment schedules and delayed research and development activities. However, as the pandemic's impact wanes, the market is regaining momentum. The rising prevalence of osteoarthritis, particularly among older adults, is a significant driver of market expansion. The availability of improved treatment options and increased public awareness are also contributing to market growth. Additionally, strategic initiatives by market players, including product launches and collaborations, are further bolstering the market's trajectory.
Regionally, North America is expected to maintain a significant share of the osteoarthritis treatment market, supported by a growing elderly population and a high prevalence of the condition. The United States, in particular, is witnessing a substantial impact due to the widespread occurrence of osteoarthritis among adults. The market in Canada and Mexico is also experiencing growth, driven by similar trends. The region benefits from robust research and development activities, government support, and the introduction of novel therapeutics. Despite the competitive landscape, with key players like Sanofi SA, Pfizer Inc., and GlaxoSmithKline plc actively participating, the market continues to evolve with new therapies and strategic partnerships.
Osteoarthritis Treatment Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Geriatric Population
-
1.2.2 Increasing Research & Development Activities and Funding for Osteoarthritis Therapeutics
-
-
1.3 Market Restraints
-
1.3.1 High Cost Associated with the Treatment Procedures
-
1.3.2 Side Effects Associated with the Available Therapeutics
-
-
1.4 Porter' s Five Forces Analysis
-
1.4.1 Bargaining Power of Suppliers
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Threat of New Entrants
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Drugs
-
2.1.1 Non-steroidal Anti-inflammatory Drugs (NSAIDs)
-
2.1.2 Corticosteroids
-
2.1.3 Hyaluronic Acid Injection
-
2.1.4 Other Drugs
-
-
2.2 By Anatomy
-
2.2.1 Ankle Osteoarthritis
-
2.2.2 Hip Osteoarthritis
-
2.2.3 Knee Osteoarthritis
-
2.2.4 Shoulder Osteoarthritis
-
2.2.5 Other Anatomies
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Osteoarthritis Treatment Market Size FAQs
How big is the Osteoarthritis Treatment Market?
The Osteoarthritis Treatment Market size is expected to reach USD 7.33 billion in 2024 and grow at a CAGR of 4.74% to reach USD 9.24 billion by 2029.
What is the current Osteoarthritis Treatment Market size?
In 2024, the Osteoarthritis Treatment Market size is expected to reach USD 7.33 billion.